Date: 08 Sep 2026

WPC Research Spotlight #4

Venue: Webinar

Website: www.worldpdcoalition.org

Event Notes:

Translating basic science into therapies for PD

Join in for the next WPC Research Spotlight with host Professor Roger Barker, PhD, as Jim Surmeier, PhD, discusses “Translating basic science into therapies for PD”!

Jim Surmeier, MD, PhD directs a research program focusing on molecular, cellular and network mechanisms governing the basal ganglia in health and disease states. Using a combination of electrophysiological, optical and genetic approaches in mouse models, this group has made major contributions to the understanding of how dopamine and other neuromodulators shape intrinsic and synaptic mechanisms underlying basal ganglia function, as well as how these processes are altered in Parkinson’s disease, Huntington’s disease and chronic pain states. Using a similar set of approaches, the group also has made significant contributions to the understanding of pathogenesis and selective neuronal vulnerability in Parkinson’s disease. These studies have implicated Cav1 Ca2+ channels and mitochondrial stress as potential disease drivers. Buttressed by epidemiological data supporting this inference, their studies have led to Phase 2 and 3 disease-modification clinical trial in early-stage Parkinson’s disease patients. This work is continuing with the hope of developing more effective strategies for slowing or stopping disease progression. His research has been supported by NINDS, NIDA, DOD, and private foundations. He serves in an editorial capacity at many journals, including Science Advances, Neuron, Movement Disorders and the Journal of Clinical Investigation.